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To investigate the feasibility of transplanting human neural progenitor cells (hNPCs) to the retina of nonimmunosuppressed
pigs, cultured hNPCs were injected into the subretinal space of 5 adult pigs after laser burns were applied to promote donor
cell integration. Postoperatively, the retinal vessels appeared normal without signs of exudation, bleeding, or subretinal elevation.
Eyes were harvested at 10–28 days. H&E consistently showed mild retinal vasculitis, depigmentation of the RPE, and marked
mononuclear cell infiltrate in the choroid adjacent to the site of transplantation. Human-specific antibodies revealed donor cells
in the subretinal space at 10–13 days and smaller numbers within the retina on days 12 and 13, with evidence suggesting a limited
degree of morphological integration; however, no cells remained at 4 weeks. The strong mononuclear cell reaction and loss of
donor cells indicate that modulation of host immunity is likely necessary for prolonged xenograft survival in this model.
1. Introduction
Neurological disorders comprise a wide spectrum of condi-
tions affecting all parts of the central nervous system (CNS),
including the brain, spinal cord, and retina. These diseases
are common, often debilitating, and generally recalcitrant to
treatment. In an effort to generate novel approaches to CNS
repair, particular attention has been given to diseases of the
retina where the biological challenges present are arguably
more circumscribed, the existing surgical techniques notably
precise, and the medical imaging and functional monitoring
capabilities relatively advanced. Although mammals do not
share the innate capacity for retinal regeneration displayed
by many teleost, urodele, and anuran species, there is now
a sizeable literature documenting the restorative potential
of transplanted stem and progenitor cells in animal models
retinal disease (as reviewed in [1]).
The types of stem and stem-like cells that have been
used as donor cells for retinal transplantation range from
embryonic stem cell [2] and induced pluripotent stem (iPS)
cells [3] to brain- and retina-derived CNS progenitor cells
[4, 5], primary rod photoreceptor precursor cells [6], and
bone marrow-derived populations such as vascular progen-
itors [7]. Gratifying results have been frequently reported,
regardless of cell type, although here it should be noted
that a number of caveats apply. Pluripotent cells typically
require partial predifferentiation into lineage-committed
progenitor cells prior to transplantation to improve the
yield of desired mature cell type and to avoid teratoma
formation. Photoreceptor precursors can be enriched from
immature transgenic murine tissue, but the isolation of
clinically significant yields of human precursors has not yet
been possible such that the translation of this approach will
likely require additional scientific advances. Currently, bone
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marrow and CNS progenitors are particularly attractive from
the standpoint of preclinical development, and of these, the
latter has the added advantage of exhibiting the capacity for
neuronal cell replacement in the diseased retina.
CNS progenitor cells have now been derived from the
brain or the retina of multiple different mammalian species,
including humans [8], and transplanted to the retina of
the mouse [9], rat [4, 9, 10], Brazilian opossum [11], pig
[12–14], cat [15], and monkey [16]. Donor cell survival
has been consistently reported over a varying range of
survival times. In none of these instances were the cells
autologous, and in the majority of cases, the recipient
animals did not receive immune suppression. The ability of
allogeneic CNS progenitor cells to survive transplantation to
immune competent hosts is robust and reproducible, but not
invariant, as has been particularly well characterized in the
mouse [17]. The apparent immune privilege status of CNS
progenitors as donor cells is a factor that might enhance the
clinical utility of these cells although an important caveat
here is attention to treatment conditions thatmight influence
expression of the major histocompatibility complex (MHC),
particularly class II antigens [18].
In addition to allografting experiments, CNS progen-
itors have been transplanted to the vitreous and retina
as xenografts. For instance, grafts of brain-derived GFP+
murine NPCs have been performed in the rat [10] and
the Brazilian opossum [11], in both cases without immune
suppression. In addition, GFP+ murine retinal progenitor
cells (RPCs) have been transplanted to the subretinal space
of the pig [12, 13]. Overall, integration and survival varied
between models and appeared to depend largely on the
degree of host immune reactivity to the grafts; however, it
is important to note that the rejection of CNS progenitor
xenografts was not invariable, and survival out to 4 weeks
was possible in some instances.
The availability of human NPCs [19, 20] and RPCs
[8, 21] has increased the need for xenogeneic animal models
for safety and efficacy testing of these cell types. Previous
reports include studies in rat [9], monkey [16], and mouse
[22]. Reported results typically included animals that were
exogenously immunosuppressed or exhibited endogenous
immune insufficiency, making the interpretation of immune
tolerance difficult. Here, we investigated the xenotransplan-
tation of brain-derived human NPCs to the subretinal space
of nonimmunosuppressed pigs.
2. Materials and Methods
2.1. Donor Cells. Donated tissue was obtained under
informed consent, and all work was performed with IRB
approval (Children’s Hospital of Orange County). The donor
cells used in this study were derived from postmortem
forebrain tissue obtained from an infant that was delivered
prematurely at 25 weeks gestational age as has been described
previously [20]. Briefly, tissue was harvested by dissection
under semisterile conditions, minced in a tissue culture
hood, and cultured in DMEM/F12-based growth medium
supplemented with BIT 9500 (Stem Cell technologies, Van-
couver) containing EGF (20 ng/mL) and bFGF (40 ng/mL)
as mitogens, as well as PDGF-AB (20 ng/mL) to retain the
potential for oligodendrocyte differentiation. Penicillin, gen-
tamicin, ciprofloxacin, and amphotericin were also included
to avoid the contamination of primary cultures. After
expansion in fibronectin-coated tissue culture flasks for
approximately 6 weeks, the resulting cell culture used in the
present study was designated SC27 [20].
2.2. Animal Recipients. Host animals were 5 juvenile female
pigs of the Danish landrace, 4 months of age, and approx-
imately 30 kg in weight. Surgery was performed in one eye
only (left) under general anesthesia. No immunosuppressive
drugs were administered. All animal work was performed
under the approval of the supervisory authorities of the
Panum Institute, University of Copenhagen and in accord
with the ARVO policy for the treatment of animals.
2.3. Transplantation. Animals were placed under general
anesthesia, and vitreoretinal surgery was performed as
previously described [12]. Briefly, the pigs were pre-anesthe-
tized with intramuscular injections consisting of midazolam,
zolazepam, tiletamine, xylazine, ketamine, and methadone.
They were then intubated, artificially ventilated, and anesthe-
tized with isoflurane/oxygen. The operative pupil was dilated
with topical phenylephrine, tropicamide, and atropine. The
surgical field was prepared and draped in the usual sterile
fashion before commencement of surgery. A localized 3-
port pars plana vitrectomy was performed and green argon
laser burns applied in a grid pattern to the area centralis
of the retina. A retinotomy was prepared and the human
cells (approximately 1 × 106) delivered via a 41-gauge needle
to the subretinal space in the region corresponding to the
laser burns. Correct graft placement was ascertained by
direct visualization at the time of injection. Chloramphenicol
was given prophylactically at the end of surgery to avoid
infection.
2.4. Postsurgical Followup and Survival Times. Animals were
followed clinically, including funduscopic examination on
a weekly basis. Survival times were 10 days, 11 days, 12
days, 13 days, and 4 weeks, at which time the animals were
placed under general anesthesia, and the previously treated
eyes were enucleated and processed for histological analysis.
Following enucleation, animals were terminated using intra-
venous sodium pentobarbital, as previously described [12].
2.5. Histology. Enucleated globes were fixed by immersion
in 4% paraformaldehyde and processed for histology as
previously described in detail [12]. Briefly, globes were
immersion fixed in 4% paraformaldehyde for 10–20minutes.
The anterior segment, including lens, was then removed,
and the posterior segment was postfixed for an additional
2 hours, again in 4% paraformaldehyde. A tissue block
including the area of interest, optic nerve head, and temporal
periphery was prepared and embedded in gelatin, and serial
12 µm sections were cut by cryostat. A subset of sections
(1 : 10) was stained with hematoxylin-eosin (H&E), and the
remainder was reserved for immunohistochemical labeling.
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Table 1: Antibodies and dilutions used.
(a) Antihuman primary antibodies
Antigen Isotype
Company,
product no.
Dilution
Human tau Mouse
monoclonal
Abcam,
ab67360
1 : 100
Human nuclei Mouse
monoclonal
Chemicon,
MAB1281
1 : 100
Human NCAM Mouse
monoclonal
Immunkemi,
NCCD561B6
1 : 50
(b) Primary antibodies against lineage markers
Antigen Isotype Company Dilution
GFAP Rabbit polyclonal DAKO 1 : 100
Cytokeratin Rabbit polyclonal DAKO 1 : 100
(c) Secondary antibodies
Fluorophore Company Dilution
FITC conjugated Jackson Immunoresearch 1 : 200
Texas red conjugated Jackson Immunoresearch 1 : 200
Table 2: Semiquantitative assessment of graft survival per pig and
time point.
Pig ID no. Survival Donor cells Distribution
211 10 days +++ SRS, retina, RPE
208 11 days ++ SRS, retina
202 12 days +++ SRS, retina
213 13 days + SRS
207 28 days −
Abbreviations: +++: many cells present, ++: moderate numbers of cells, +: a
few cells,−: no cells, SRS: subretinal space, RPE: retinal pigment epithelium.
2.6. Immunohistochemistry. Sections were processed with
primary antibodies (Table 1) in a moist chamber at 4◦C for
16–18 hours, followed by rinsing in PBS/Triton X-100, prior
to labeling with secondary antibodies (Table 1) for 1-2 hours
in the dark at room temperature, as previously described
[12, 14]. Negative controls with primary antibodies omitted
were also performed. Sections were imaged through an
epifluorescence microscope.
3. Results and Discussion
A total of 5 pigs received subretinal xenografts of human
neural progenitor cells. Of these, 4 pigs were sacrificed after
10–13 days and 1 pig after 28 days. Results of the antihuman
immunolabeling were most consistent with the antinuclei
antibody (Table 1). Using this reagent, surviving human
donor cells were identified in the initial 4 animals, but not
in the last (Table 2). The amount of surviving cells varied
between recipients, as did the distribution of cells in host
tissues; however, a number of points can be derived from
these data.
500 µm
Figure 1: Identification of donor cells, graft placement, and
survival at 10 days. Donor cells were identified via anti-human
nuclear immunolabeling and an FITC-conjugated secondary anti-
body. Abundant human nuclear profiles (green) extend in a line
horizontally across the image, the location of which is the subretinal
space, corresponding precisely to the initial site of deposition. In
this particular view, there is no evidence of migration or integration
of donor cells into host tissues. The retina, seen here as the faintly
striated, unlabelled tissue directly beneath the grafted cells, appears
detached from the overlying structures; however, this was not seen
in vivo and is an artifact of the method of histological processing
employed.
It is clear that hNPCs can survive in the subretinal space
(SRS) of nonimmunosuppressed pigs for a minimum of 13
days. The immunohistochemical results also back up the
observations made at the time of surgery regarding effective
placement of the grafts in the subretinal space (Figure 1).
In all cases in which surviving human NPCs were present,
a portion were located in the subretinal space, and these
represented the majority of the cells. In addition, there was
a widespread lateral distribution of the hNPCs within the
host SRS, tending to confirm the clinical observation that
the retinal bleb formed at the time of injection had resolved
with even distribution of the grafted cells in the SRS, despite
later artifactual detachment of the neural retina during tissue
processing (Figure 1).
The donor cells remaining in the SRS strongly expressed
the glial marker GFAP, suggesting the possibility of a
predominant differentiation along astroglial lines by these
cells (Figure 2). GFAP was also expressed in the host retina,
likely as a reaction to prior surgical intervention, including
the application of laser burns. It is also clear that donor
hNPCs were capable of migration into adjacent host tissues
over the restricted time course of this study. There was
evidence of donor profiles within the neural retina, and
these profiles tended to exhibit nonrandom localization,
favoring (but not limited to) sites of prior laser application
and showing preference for certain host cytoarchitectural
landmarks, such as the inner plexiform layer (IPL; Figure 3).
Although nuclear labeling does not allow the examination of
donor cell morphology, in the example just cited the relative
positional organization of the donor nuclei appears to reflect
cytoarchitectural cues to the extent that there is sublaminar
positioning within the central zone of the IPL, as opposed
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Figure 2: Xenografted human NPCs express GFAP in the porcine
subretinal space. Donor cell identified with anti-human nuclear
antibody exhibits cytoplasmic labeling for the astroglial marker glial
fibrillary acidic protein (GFAP, red), which is also expressed by
activated glial cells in the underlying host neural retina. Survival
= 10 days.
Figure 3: Xenografted human NPCs within the porcine retina.
Donor cells were identified via anti-human nuclear immunola-
beling and FITC-conjugated secondary (green). In addition to
abundant cells within the subretinal space (top of image), labeled
profiles were also evident within specific layers of the host retina,
including the outer nuclear layer (horizontal arrow) and the inner
plexiform layer (upward pointing arrows). In the latter case, the
donor cells appear to be specifically positioned within a relatively
restricted sublaminar zone. Survival = 12 days.
to the boundary regions of that layer. This is suggestive of at
least some degree of morphological integration; however, no
further conclusions regarding cell fate can be drawn.
Additional evidence of donor cell integration is provided
by the examination of the retinal pigment epithelium (RPE).
Immunolabeling indicates the migration of hRPCs from
the SRS into circumscribed regions of the RPE monolayer,
with some degree of morphological integration (Figure 4).
The donor cell nuclei localize precisely to regions where
a gap is present in the host RPE monolayer, as evidenced
by discontinuity of cytokeratin labeling. It would appear
that the donor cells have been attracted to an area of laser
injury and have reformed a donor-derived monolayer in
50 µm
Figure 4: Xenografted hNPCs incorporated into the porcine RPE
monolayer. Donor cells are labeled with anti-human nuclear label
(upper left, yellow-green). In this case, a single donor profile is
seen within the subretinal space, and the remainder are located
at the level of the retinal pigment epithelium (RPE), labeled here
with anticytokeratin (red). The human donor cells occupy a region
corresponding to a focal discontinuity in the cytokeratin labeling.
Survival = 10 days.
response. Note that this “repair” is not perfect: there is
a degree of disorganization at the junction between graft
and host monolayers, as well as a lack of cytokeratin
expression by the host cells. The hRPCs have therefore
been not differentiated into mature RPE cells, and therefore,
this situation does not comprise functional integration,
neither does it rule out the possibility should longer survival
times be obtainable. Interestingly, very similar results were
seen following xenografts of murine retinal progenitor cells
(RPCs) to the porcine SRS [12].
Finally, it is clear that human-to-pig xenografts evoke a
powerful immune response, even when placed within the
immunologically privileged confines of the SRS (Figure 5).
The rejection response seen is disproportionally choroidal in
origin, with little evidence of retinal involvement until late
in the process, likely explaining the preservation of donor
cells at the early time points, when the choroid already con-
tained a cellular infiltrate. Both the timing and pathological
features of this response are quite similar to those already
documented for mouse-to-pig xenografts [12, 13]. In either
case, survival out to 2 weeks is obtainable without host
immune suppression, whereas loss of the graft was invariable
at 4 weeks. An important but unresolved issue concerns
the potential role of laser treatment in the inflammatory
response seen here and in the prior studies. Laser application
serves to increase donor cell integration yet at the same
time leads to focal injury of the RPE and likely alters the
blood-retinal barrier. Thus, laser burns could exacerbate an
underlying lack of tolerance for xenogeneic cells. In contrast,
4-week donor cell survival without immunosuppression was
seen following xenotransplantation of mouse NPCs to the
eye of the early postnatal Brazilian opossum [11]. Choroidal
infiltrates were not seen in monkeys that received hNPC
xenografts although varying degrees of immune suppression
were used in that study [16]. Therefore, it appears that the
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Figure 5: Evaluation of host tissue and cellular response in the
area of laser burn. A subset of sections from eyes with xenografts
were stained with H&E (a) to evaluate the host tissue and cellular
responses, while adjacent sections were immunolabeled to identify
human donor cells (b). (a) The area of laser injury can be identified
by the focal disturbance of the overlying pigmented layers, as
well as localized disruption of the underlying retina. An abnormal
adhesion between the retina and overlying structures is present in
this location that bridges the subretinal space. A densemononuclear
infiltrate is present in the choroid (top), consistent with the
development of a strong immune response. (b) Immunoimaging
reveals the presence of many donor cells, which have preferentially
congregated in the area of laser injury and appear to contribute
to the subretinal adhesion. A few donor profiles are present in the
neural retina in the immediate vicinity of the laser injury. Survival
= 10 days.
porcine immune system represents a particularly formidable
barrier to long-term xenograft survival.
4. Conclusions
The pig represents a large animal model of considerable
recent interest for the development of novel surgical treat-
ments, including stem cell transplantation. In previous work,
we have shown that allogeneic grafts of CNS progenitor cells
are well tolerated in the porcine retina, subretinal space,
and vitreous cavity in the absence of immune suppression.
However, we have also shown that xenografted murine CNS
progenitors are rapidly rejected under similar conditions
[12] and that the nature of the rejection response points
to mouse and pig being immunologically discordant species
[13]. Here, we show that human neural progenitor cells
can integrate into the porcine retina; however, survival
is limited to a brief window of approximately 2 weeks,
beyond which an intense cellular response destroys the
graft with considerable effacement of adjacent host tissues.
These results are quite similar to our previous findings with
mouse-to-pig xenografts. Even during the first 2 weeks, while
human donor cells were surviving, intense hypercellularity
was already evident in the adjacent choroid at the earliest
time point examined (10 days), indicating a host cellular
response to the graft. Of note, the reaction was elicited
using a relatively well-tolerated cell type that was placed in a
location known to exhibit aspects of immune privilege. Since
both of these factors should tend to mitigate immunological
responsivity, it can be anticipated that the outcome would
not be better, and likelyworse, following xenotransplantation
of more immunogenic human cell types (e.g., those with
prominent MHC class II expression) to conventional graft
sites (i.e., lacking immune privilege). With these limitations
noted, it may still be the case that substantially longer
survival of human-to-pig xenografts could be obtained
under conditions in which the host immune response is
diminished, for instance, via exogenous suppression, innate
insufficiency, or host humanization. Given the potential
utility of the pig in translational development of regenerative
therapies, it would seem worthwhile to further explore this
possibility, despite the challenges faced.
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